P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

Clinical trial NCT00390845 · COMPLETED

Trial details

NCT number: NCT00390845
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain, Neuropathic

Start date: 2006-08-30
Primary completion: 2008-08-11
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.